世界の経皮用ホルモンパッチ市場インサイト・予測（～2027年）

• 英文タイトル：Global Hormonal Transdermal Patches Market Insights and Forecast to 2027

• レポートコード：QY2108PAL3896 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は経皮用ホルモンパッチの世界市場の現状について調査・分析し、2027年までの市場を予測しました。経皮用ホルモンパッチの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（避妊パッチ、エストラジオールパッチ、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・経皮用ホルモンパッチの世界市場概要 ・メーカー別の競争状況、市場シェア ・経皮用ホルモンパッチの種類別市場規模：避妊パッチ、エストラジオールパッチ、その他 ・経皮用ホルモンパッチの用途別市場規模：病院、クリニック ・北米の経皮用ホルモンパッチ市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの経皮用ホルモンパッチ市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの経皮用ホルモンパッチ市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の経皮用ホルモンパッチ市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの経皮用ホルモンパッチ市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Xulane、Twirla、Planned Parenthood、Lvye Pharma、Novartis、Bayer Healthcare Pharmaceuticals、Watson Labs、Women First Healthcare Inc、Noven、AbbVie、Lumara Health、ANI Pharmaceuticals ・経皮用ホルモンパッチのバリューチェーン・販売チャネル分析 ・経皮用ホルモンパッチの世界市場動向

Market Analysis and Insights: Global Hormonal Transdermal Patches Market
The global Hormonal Transdermal Patches market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Hormonal Transdermal Patches Scope and Segment
Hormonal Transdermal Patches market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hormonal Transdermal Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Contraceptive Patches
Estradiol Patches
Others

Segment by Application
Hospital
Clinic

By Company
Xulane
Twirla
Planned Parenthood
Lvye Pharma
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Hormonal Transdermal Patches Product Introduction
1.2 Market by Type
1.2.1 Global Hormonal Transdermal Patches Market Size Growth Rate by Type
1.2.2 Contraceptive Patches
1.2.3 Estradiol Patches
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hormonal Transdermal Patches Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hormonal Transdermal Patches Sales Estimates and Forecasts 2016-2027
2.2 Global Hormonal Transdermal Patches Revenue Estimates and Forecasts 2016-2027
2.3 Global Hormonal Transdermal Patches Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Hormonal Transdermal Patches Regions by Sales
2.4.1 Global Top Hormonal Transdermal Patches Regions by Sales (2016-2021)
2.4.2 Global Top Hormonal Transdermal Patches Regions by Sales (2022-2027)
2.5 Global Top Hormonal Transdermal Patches Regions by Revenue
2.5.1 Global Top Hormonal Transdermal Patches Regions by Revenue (2016-2021)
2.5.2 Global Top Hormonal Transdermal Patches Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Hormonal Transdermal Patches Sales by Manufacturers
3.1.1 Global Top Hormonal Transdermal Patches Manufacturers by Sales (2016-2021)
3.1.2 Global Top Hormonal Transdermal Patches Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Hormonal Transdermal Patches Sales in 2020
3.2 Global Hormonal Transdermal Patches Revenue by Manufacturers
3.2.1 Global Top Hormonal Transdermal Patches Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Hormonal Transdermal Patches Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Hormonal Transdermal Patches Revenue in 2020
3.3 Global Hormonal Transdermal Patches Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hormonal Transdermal Patches Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Hormonal Transdermal Patches Sales by Type
4.1.1 Global Hormonal Transdermal Patches Historical Sales by Type (2016-2021)
4.1.2 Global Hormonal Transdermal Patches Forecasted Sales by Type (2022-2027)
4.1.3 Global Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
4.2 Global Hormonal Transdermal Patches Revenue by Type
4.2.1 Global Hormonal Transdermal Patches Historical Revenue by Type (2016-2021)
4.2.2 Global Hormonal Transdermal Patches Forecasted Revenue by Type (2022-2027)
4.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
4.3 Global Hormonal Transdermal Patches Price by Type
4.3.1 Global Hormonal Transdermal Patches Price by Type (2016-2021)
4.3.2 Global Hormonal Transdermal Patches Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Hormonal Transdermal Patches Sales by Application
5.1.1 Global Hormonal Transdermal Patches Historical Sales by Application (2016-2021)
5.1.2 Global Hormonal Transdermal Patches Forecasted Sales by Application (2022-2027)
5.1.3 Global Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
5.2 Global Hormonal Transdermal Patches Revenue by Application
5.2.1 Global Hormonal Transdermal Patches Historical Revenue by Application (2016-2021)
5.2.2 Global Hormonal Transdermal Patches Forecasted Revenue by Application (2022-2027)
5.2.3 Global Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
5.3 Global Hormonal Transdermal Patches Price by Application
5.3.1 Global Hormonal Transdermal Patches Price by Application (2016-2021)
5.3.2 Global Hormonal Transdermal Patches Price Forecast by Application (2022-2027)

6 North America
6.1 North America Hormonal Transdermal Patches Market Size by Type
6.1.1 North America Hormonal Transdermal Patches Sales by Type (2016-2027)
6.1.2 North America Hormonal Transdermal Patches Revenue by Type (2016-2027)
6.2 North America Hormonal Transdermal Patches Market Size by Application
6.2.1 North America Hormonal Transdermal Patches Sales by Application (2016-2027)
6.2.2 North America Hormonal Transdermal Patches Revenue by Application (2016-2027)
6.3 North America Hormonal Transdermal Patches Market Size by Country
6.3.1 North America Hormonal Transdermal Patches Sales by Country (2016-2027)
6.3.2 North America Hormonal Transdermal Patches Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Hormonal Transdermal Patches Market Size by Type
7.1.1 Europe Hormonal Transdermal Patches Sales by Type (2016-2027)
7.1.2 Europe Hormonal Transdermal Patches Revenue by Type (2016-2027)
7.2 Europe Hormonal Transdermal Patches Market Size by Application
7.2.1 Europe Hormonal Transdermal Patches Sales by Application (2016-2027)
7.2.2 Europe Hormonal Transdermal Patches Revenue by Application (2016-2027)
7.3 Europe Hormonal Transdermal Patches Market Size by Country
7.3.1 Europe Hormonal Transdermal Patches Sales by Country (2016-2027)
7.3.2 Europe Hormonal Transdermal Patches Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Hormonal Transdermal Patches Market Size by Type
8.1.1 Asia Pacific Hormonal Transdermal Patches Sales by Type (2016-2027)
8.1.2 Asia Pacific Hormonal Transdermal Patches Revenue by Type (2016-2027)
8.2 Asia Pacific Hormonal Transdermal Patches Market Size by Application
8.2.1 Asia Pacific Hormonal Transdermal Patches Sales by Application (2016-2027)
8.2.2 Asia Pacific Hormonal Transdermal Patches Revenue by Application (2016-2027)
8.3 Asia Pacific Hormonal Transdermal Patches Market Size by Region
8.3.1 Asia Pacific Hormonal Transdermal Patches Sales by Region (2016-2027)
8.3.2 Asia Pacific Hormonal Transdermal Patches Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Hormonal Transdermal Patches Market Size by Type
9.1.1 Latin America Hormonal Transdermal Patches Sales by Type (2016-2027)
9.1.2 Latin America Hormonal Transdermal Patches Revenue by Type (2016-2027)
9.2 Latin America Hormonal Transdermal Patches Market Size by Application
9.2.1 Latin America Hormonal Transdermal Patches Sales by Application (2016-2027)
9.2.2 Latin America Hormonal Transdermal Patches Revenue by Application (2016-2027)
9.3 Latin America Hormonal Transdermal Patches Market Size by Country
9.3.1 Latin America Hormonal Transdermal Patches Sales by Country (2016-2027)
9.3.2 Latin America Hormonal Transdermal Patches Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Hormonal Transdermal Patches Market Size by Type
10.1.1 Middle East and Africa Hormonal Transdermal Patches Sales by Type (2016-2027)
10.1.2 Middle East and Africa Hormonal Transdermal Patches Revenue by Type (2016-2027)
10.2 Middle East and Africa Hormonal Transdermal Patches Market Size by Application
10.2.1 Middle East and Africa Hormonal Transdermal Patches Sales by Application (2016-2027)
10.2.2 Middle East and Africa Hormonal Transdermal Patches Revenue by Application (2016-2027)
10.3 Middle East and Africa Hormonal Transdermal Patches Market Size by Country
10.3.1 Middle East and Africa Hormonal Transdermal Patches Sales by Country (2016-2027)
10.3.2 Middle East and Africa Hormonal Transdermal Patches Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Xulane
11.1.1 Xulane Corporation Information
11.1.2 Xulane Overview
11.1.3 Xulane Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Xulane Hormonal Transdermal Patches Product Description
11.1.5 Xulane Recent Developments
11.2 Twirla
11.2.1 Twirla Corporation Information
11.2.2 Twirla Overview
11.2.3 Twirla Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Twirla Hormonal Transdermal Patches Product Description
11.2.5 Twirla Recent Developments
11.3 Planned Parenthood
11.3.1 Planned Parenthood Corporation Information
11.3.2 Planned Parenthood Overview
11.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Planned Parenthood Hormonal Transdermal Patches Product Description
11.3.5 Planned Parenthood Recent Developments
11.4 Lvye Pharma
11.4.1 Lvye Pharma Corporation Information
11.4.2 Lvye Pharma Overview
11.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Lvye Pharma Hormonal Transdermal Patches Product Description
11.4.5 Lvye Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Novartis Hormonal Transdermal Patches Product Description
11.5.5 Novartis Recent Developments
11.6 Bayer Healthcare Pharmaceuticals
11.6.1 Bayer Healthcare Pharmaceuticals Corporation Information
11.6.2 Bayer Healthcare Pharmaceuticals Overview
11.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Description
11.6.5 Bayer Healthcare Pharmaceuticals Recent Developments
11.7 Watson Labs
11.7.1 Watson Labs Corporation Information
11.7.2 Watson Labs Overview
11.7.3 Watson Labs Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Watson Labs Hormonal Transdermal Patches Product Description
11.7.5 Watson Labs Recent Developments
11.8 Women First Healthcare Inc
11.8.1 Women First Healthcare Inc Corporation Information
11.8.2 Women First Healthcare Inc Overview
11.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Women First Healthcare Inc Hormonal Transdermal Patches Product Description
11.8.5 Women First Healthcare Inc Recent Developments
11.9 Noven
11.9.1 Noven Corporation Information
11.9.2 Noven Overview
11.9.3 Noven Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Noven Hormonal Transdermal Patches Product Description
11.9.5 Noven Recent Developments
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Overview
11.10.3 AbbVie Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 AbbVie Hormonal Transdermal Patches Product Description
11.10.5 AbbVie Recent Developments
11.11 Lumara Health
11.11.1 Lumara Health Corporation Information
11.11.2 Lumara Health Overview
11.11.3 Lumara Health Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Lumara Health Hormonal Transdermal Patches Product Description
11.11.5 Lumara Health Recent Developments
11.12 ANI Pharmaceuticals
11.12.1 ANI Pharmaceuticals Corporation Information
11.12.2 ANI Pharmaceuticals Overview
11.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 ANI Pharmaceuticals Hormonal Transdermal Patches Product Description
11.12.5 ANI Pharmaceuticals Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Hormonal Transdermal Patches Value Chain Analysis
12.2 Hormonal Transdermal Patches Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormonal Transdermal Patches Production Mode & Process
12.4 Hormonal Transdermal Patches Sales and Marketing
12.4.1 Hormonal Transdermal Patches Sales Channels
12.4.2 Hormonal Transdermal Patches Distributors
12.5 Hormonal Transdermal Patches Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hormonal Transdermal Patches Industry Trends
13.2 Hormonal Transdermal Patches Market Drivers
13.3 Hormonal Transdermal Patches Market Challenges
13.4 Hormonal Transdermal Patches Market Restraints

14 Key Findings in The Global Hormonal Transdermal Patches Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Hormonal Transdermal Patches Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Contraceptive Patches
Table 3. Major Manufacturers of Estradiol Patches
Table 4. Major Manufacturers of Others
Table 5. Global Hormonal Transdermal Patches Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Hormonal Transdermal Patches Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Hormonal Transdermal Patches Sales by Region (2016-2021) & (K Units)
Table 8. Global Hormonal Transdermal Patches Sales Market Share by Region (2016-2021)
Table 9. Global Hormonal Transdermal Patches Sales by Region (2022-2027) & (K Units)
Table 10. Global Hormonal Transdermal Patches Sales Market Share by Region (2022-2027)
Table 11. Global Hormonal Transdermal Patches Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Hormonal Transdermal Patches Revenue Market Share by Region (2016-2021)
Table 13. Global Hormonal Transdermal Patches Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Hormonal Transdermal Patches Revenue Market Share by Region (2022-2027)
Table 15. Global Hormonal Transdermal Patches Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Hormonal Transdermal Patches Sales Share by Manufacturers (2016-2021)
Table 17. Global Hormonal Transdermal Patches Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Hormonal Transdermal Patches Revenue Share by Manufacturers (2016-2021)
Table 19. Hormonal Transdermal Patches Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Hormonal Transdermal Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Hormonal Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Transdermal Patches as of 2020)
Table 22. Hormonal Transdermal Patches Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Hormonal Transdermal Patches Product Offered
Table 24. Date of Manufacturers Enter into Hormonal Transdermal Patches Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hormonal Transdermal Patches Sales by Type (2016-2021) & (K Units)
Table 27. Global Hormonal Transdermal Patches Sales by Type (2022-2027) & (K Units)
Table 28. Global Hormonal Transdermal Patches Sales Share by Type (2016-2021)
Table 29. Global Hormonal Transdermal Patches Sales Share by Type (2022-2027)
Table 30. Global Hormonal Transdermal Patches Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Hormonal Transdermal Patches Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Hormonal Transdermal Patches Revenue Share by Type (2016-2021)
Table 33. Global Hormonal Transdermal Patches Revenue Share by Type (2022-2027)
Table 34. Hormonal Transdermal Patches Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Hormonal Transdermal Patches Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Hormonal Transdermal Patches Sales by Application (2016-2021) & (K Units)
Table 37. Global Hormonal Transdermal Patches Sales by Application (2022-2027) & (K Units)
Table 38. Global Hormonal Transdermal Patches Sales Share by Application (2016-2021)
Table 39. Global Hormonal Transdermal Patches Sales Share by Application (2022-2027)
Table 40. Global Hormonal Transdermal Patches Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Hormonal Transdermal Patches Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Hormonal Transdermal Patches Revenue Share by Application (2016-2021)
Table 43. Global Hormonal Transdermal Patches Revenue Share by Application (2022-2027)
Table 44. Hormonal Transdermal Patches Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Hormonal Transdermal Patches Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Hormonal Transdermal Patches Sales by Type (2016-2021) & (K Units)
Table 47. North America Hormonal Transdermal Patches Sales by Type (2022-2027) & (K Units)
Table 48. North America Hormonal Transdermal Patches Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Hormonal Transdermal Patches Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Hormonal Transdermal Patches Sales by Application (2016-2021) & (K Units)
Table 51. North America Hormonal Transdermal Patches Sales by Application (2022-2027) & (K Units)
Table 52. North America Hormonal Transdermal Patches Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Hormonal Transdermal Patches Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Hormonal Transdermal Patches Sales by Country (2016-2021) & (K Units)
Table 55. North America Hormonal Transdermal Patches Sales by Country (2022-2027) & (K Units)
Table 56. North America Hormonal Transdermal Patches Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Hormonal Transdermal Patches Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Hormonal Transdermal Patches Sales by Type (2016-2021) & (K Units)
Table 59. Europe Hormonal Transdermal Patches Sales by Type (2022-2027) & (K Units)
Table 60. Europe Hormonal Transdermal Patches Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Hormonal Transdermal Patches Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Hormonal Transdermal Patches Sales by Application (2016-2021) & (K Units)
Table 63. Europe Hormonal Transdermal Patches Sales by Application (2022-2027) & (K Units)
Table 64. Europe Hormonal Transdermal Patches Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Hormonal Transdermal Patches Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Hormonal Transdermal Patches Sales by Country (2016-2021) & (K Units)
Table 67. Europe Hormonal Transdermal Patches Sales by Country (2022-2027) & (K Units)
Table 68. Europe Hormonal Transdermal Patches Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Hormonal Transdermal Patches Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Hormonal Transdermal Patches Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Hormonal Transdermal Patches Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Hormonal Transdermal Patches Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Hormonal Transdermal Patches Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Hormonal Transdermal Patches Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Hormonal Transdermal Patches Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Hormonal Transdermal Patches Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Hormonal Transdermal Patches Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Hormonal Transdermal Patches Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Hormonal Transdermal Patches Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Hormonal Transdermal Patches Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Hormonal Transdermal Patches Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Hormonal Transdermal Patches Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Hormonal Transdermal Patches Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Hormonal Transdermal Patches Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Hormonal Transdermal Patches Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Hormonal Transdermal Patches Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Hormonal Transdermal Patches Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Hormonal Transdermal Patches Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Hormonal Transdermal Patches Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Hormonal Transdermal Patches Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Hormonal Transdermal Patches Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Hormonal Transdermal Patches Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Hormonal Transdermal Patches Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Hormonal Transdermal Patches Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Hormonal Transdermal Patches Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Hormonal Transdermal Patches Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Hormonal Transdermal Patches Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Hormonal Transdermal Patches Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Hormonal Transdermal Patches Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Hormonal Transdermal Patches Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Hormonal Transdermal Patches Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Hormonal Transdermal Patches Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Hormonal Transdermal Patches Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Hormonal Transdermal Patches Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Hormonal Transdermal Patches Revenue by Country (2022-2027) & (US$ Million)
Table 106. Xulane Corporation Information
Table 107. Xulane Description and Major Businesses
Table 108. Xulane Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Xulane Hormonal Transdermal Patches Product
Table 110. Xulane Recent Developments
Table 111. Twirla Corporation Information
Table 112. Twirla Description and Major Businesses
Table 113. Twirla Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Twirla Hormonal Transdermal Patches Product
Table 115. Twirla Recent Developments
Table 116. Planned Parenthood Corporation Information
Table 117. Planned Parenthood Description and Major Businesses
Table 118. Planned Parenthood Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Planned Parenthood Hormonal Transdermal Patches Product
Table 120. Planned Parenthood Recent Developments
Table 121. Lvye Pharma Corporation Information
Table 122. Lvye Pharma Description and Major Businesses
Table 123. Lvye Pharma Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Lvye Pharma Hormonal Transdermal Patches Product
Table 125. Lvye Pharma Recent Developments
Table 126. Novartis Corporation Information
Table 127. Novartis Description and Major Businesses
Table 128. Novartis Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Novartis Hormonal Transdermal Patches Product
Table 130. Novartis Recent Developments
Table 131. Bayer Healthcare Pharmaceuticals Corporation Information
Table 132. Bayer Healthcare Pharmaceuticals Description and Major Businesses
Table 133. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product
Table 135. Bayer Healthcare Pharmaceuticals Recent Developments
Table 136. Watson Labs Corporation Information
Table 137. Watson Labs Description and Major Businesses
Table 138. Watson Labs Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Watson Labs Hormonal Transdermal Patches Product
Table 140. Watson Labs Recent Developments
Table 141. Women First Healthcare Inc Corporation Information
Table 142. Women First Healthcare Inc Description and Major Businesses
Table 143. Women First Healthcare Inc Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Women First Healthcare Inc Hormonal Transdermal Patches Product
Table 145. Women First Healthcare Inc Recent Developments
Table 146. Noven Corporation Information
Table 147. Noven Description and Major Businesses
Table 148. Noven Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Noven Hormonal Transdermal Patches Product
Table 150. Noven Recent Developments
Table 151. AbbVie Corporation Information
Table 152. AbbVie Description and Major Businesses
Table 153. AbbVie Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. AbbVie Hormonal Transdermal Patches Product
Table 155. AbbVie Recent Developments
Table 156. Lumara Health Corporation Information
Table 157. Lumara Health Description and Major Businesses
Table 158. Lumara Health Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. Lumara Health Hormonal Transdermal Patches Product
Table 160. Lumara Health Recent Developments
Table 161. ANI Pharmaceuticals Corporation Information
Table 162. ANI Pharmaceuticals Description and Major Businesses
Table 163. ANI Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. ANI Pharmaceuticals Hormonal Transdermal Patches Product
Table 165. ANI Pharmaceuticals Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Hormonal Transdermal Patches Distributors List
Table 169. Hormonal Transdermal Patches Customers List
Table 170. Hormonal Transdermal Patches Market Trends
Table 171. Hormonal Transdermal Patches Market Drivers
Table 172. Hormonal Transdermal Patches Market Challenges
Table 173. Hormonal Transdermal Patches Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormonal Transdermal Patches Product Picture
Figure 2. Global Hormonal Transdermal Patches Market Share by Type in 2020 & 2027
Figure 3. Contraceptive Patches Product Picture
Figure 4. Estradiol Patches Product Picture
Figure 5. Others Product Picture
Figure 6. Global Hormonal Transdermal Patches Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Hormonal Transdermal Patches Report Years Considered
Figure 10. Global Hormonal Transdermal Patches Sales 2016-2027 (K Units)
Figure 11. Global Hormonal Transdermal Patches Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hormonal Transdermal Patches Revenue 2016-2027 (US$ Million)
Figure 13. Global Hormonal Transdermal Patches Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Hormonal Transdermal Patches Sales Market Share by Region (2016-2021)
Figure 15. Global Hormonal Transdermal Patches Sales Market Share by Region (2022-2027)
Figure 16. North America Hormonal Transdermal Patches Sales YoY (2016-2027) & (K Units)
Figure 17. North America Hormonal Transdermal Patches Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Hormonal Transdermal Patches Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Hormonal Transdermal Patches Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Hormonal Transdermal Patches Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Hormonal Transdermal Patches Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Hormonal Transdermal Patches Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Hormonal Transdermal Patches Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Hormonal Transdermal Patches Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Hormonal Transdermal Patches Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Hormonal Transdermal Patches Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Hormonal Transdermal Patches Revenue in 2020
Figure 28. Hormonal Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
Figure 30. Global Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
Figure 31. Global Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
Figure 32. Global Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
Figure 33. North America Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
Figure 34. North America Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
Figure 35. North America Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
Figure 36. North America Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
Figure 37. North America Hormonal Transdermal Patches Sales Share by Country (2016-2027)
Figure 38. North America Hormonal Transdermal Patches Revenue Share by Country (2016-2027)
Figure 39. United States Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
Figure 42. Europe Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
Figure 43. Europe Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
Figure 44. Europe Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
Figure 45. Europe Hormonal Transdermal Patches Sales Share by Country (2016-2027)
Figure 46. Europe Hormonal Transdermal Patches Revenue Share by Country (2016-2027)
Figure 47. Germany Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 48. France Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Hormonal Transdermal Patches Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Hormonal Transdermal Patches Revenue Share by Region (2016-2027)
Figure 58. China Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 61. India Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
Figure 68. Latin America Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
Figure 70. Latin America Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Hormonal Transdermal Patches Sales Share by Country (2016-2027)
Figure 72. Latin America Hormonal Transdermal Patches Revenue Share by Country (2016-2027)
Figure 73. Mexico Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Hormonal Transdermal Patches Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Hormonal Transdermal Patches Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Hormonal Transdermal Patches Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Hormonal Transdermal Patches Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Hormonal Transdermal Patches Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Hormonal Transdermal Patches Revenue Share by Country (2016-2027)
Figure 82. Turkey Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Hormonal Transdermal Patches Revenue (2016-2027) & (US$ Million)
Figure 85. Hormonal Transdermal Patches Value Chain
Figure 86. Hormonal Transdermal Patches Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---